Clinical injection auxiliary device for endocrine
By designing the auxiliary mechanism and feedback controller for endocrine clinical injection auxiliary devices, the pain and fear brought by the insulin pen needle are solved, and precise dose control and efficient utilization of resources are achieved.
Patent Information
- Application Number
- CN202510825124.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-06-19
- Publication Date
- 2025-08-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing insulin pen is a split structure, which causes pain and fear to the needle when used, while increasing resource waste and consumption expenditure.
An endocrine clinical injection auxiliary device is designed, including a pen holder, a refill holder and a pen cover. Using the sliding sleeve, pressure spring and protective sleeve in the auxiliary mechanism, the needle cover is covered by the squeezing of the pressure spring, reducing pain, and precise dose control and operation simplified through the feedback controller and smart chip.
Eliminates users' fear of needles, reduces injection pain, and improves operation accuracy and reuse, reducing resource waste.
Smart Images

Figure CN120514969A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, in particular to an injection assisting device for endocrinology clinics. Background Art
[0002] Insulin pens eliminate the tedious process of extracting insulin from insulin vials with syringes, saving patients the embarrassment of injecting insulin in public places and making insulin injection more convenient for patients with poor eyesight or even blindness.
[0003] Existing insulin pens all have a split structure and are injected by replacing a detachable needle and pen cartridge holder. However, the needle makes some users feel fearful when using it, and traditional needles cause severe pain when injected subcutaneously, resulting in a poor user experience. The needle also needs to be replaced after each use, which increases consumer expenditure and causes waste of resources.
[0004] In view of the above problems, an injection assisting device for endocrinology clinic is proposed. Summary of the Invention
[0005] The purpose of the present invention is to provide an injection assisting device for endocrinology clinics, which solves the problem in the background art that the injection needle in the existing islet pen causes severe pain and fear to the user.
[0006] To achieve the above-mentioned purpose, the present invention provides the following technical solutions: an injection auxiliary device for endocrinology clinic, comprising: a pen barrel, a refill rack and a pen cover; the pen barrel and the refill rack are detachably connected, a needle is provided at one end of the refill rack, and an auxiliary mechanism is provided on the outer wall of the refill rack, the auxiliary mechanism includes a sliding sleeve, a pressure spring and a base plate, the end of the needle close to the refill rack is fixedly connected to the base plate, the bottom plate is detachably connected to the refill rack, the outer wall of the needle is fixedly connected to the sliding sleeve, a sliding groove is provided on the outer wall of the sliding sleeve, a plurality of pressure springs are fixedly connected to the side of the base plate close to the needle, the pressure spring is located inside the sliding groove, a protective cover is slidably connected to the inside of the sliding groove, and the protective cover is fixedly connected to the pressure spring.
[0007] As a further description of the above technical solution: the outer side wall of the pen holder is fixedly connected with a feedback controller.
[0008] As a further description of the above technical solution: the front end of the needle is fixedly connected to an injection needle.
[0009] As a further description of the above technical solution: a pen cap is detachably connected to the outer side of the protective sleeve, and the pen cap is located at one end of the injection needle.
[0010] As a further description of the above technical solution: the bottom end of the pen holder is fixedly connected with a rope buckle.
[0011] As a further description of the above technical solution: a silicone sleeve adapted to the injection needle is fixedly connected to the interior of the pen cap.
[0012] Compared with the prior art, the present invention has the following beneficial effects:
[0013] The present invention provides an injection assisting device for endocrinology clinics, which protects the needle through an auxiliary mechanism on the outside of the refill holder, thereby eliminating the user's fear of directly seeing the needle. The needle is covered by squeezing the protective cover with a pressure spring, and the protective cover squeezes the pressure spring to slide in the slide groove, so that the injection needle is subjected to pressure during use and can be directly inserted subcutaneously for injection. The injection needle design can reduce the pain caused by traditional needles. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 It is a schematic diagram of the three-dimensional structure of the present invention;
[0015] Figure 2 It is a schematic cross-sectional view of the present invention;
[0016] Figure 3 It is a structural schematic diagram of the auxiliary mechanism in the present invention.
[0017] In the figure: 1. Pen holder; 2. Pen core holder; 3. Pen cap; 4. Needle; 5. Auxiliary mechanism; 501. Slide; 502. Pressure spring; 503. Bottom plate; 504. Slide; 505. Protective cover; 6. Feedback controller; 7. Injection needle; 8. Rope buckle; 9. Silicone cover. DETAILED DESCRIPTION
[0018] The following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.
[0019] In order to further understand the content of the present invention, the present invention is described in detail with reference to the accompanying drawings.
[0020] Combine Figure 1 、 Figure 2 and Figure 3, an injection auxiliary device for endocrinology clinic, comprising: a pen barrel 1, a refill frame 2 and a pen cover 3; the pen barrel 1 and the refill frame 2 are detachably connected, a needle 4 is provided at one end of the refill frame 2, an auxiliary mechanism 5 is provided on the outer wall of the refill frame 2, the auxiliary mechanism 5 comprises a sliding sleeve 501, a pressure spring 502 and a bottom plate 503, the end of the needle 4 close to the refill frame 2 is fixedly connected to the bottom plate 503, the outer wall of the needle 4 is fixedly connected to the sliding sleeve 501, the outer wall of the sliding sleeve 501 is provided with a sliding groove 504, and a side of the bottom plate 503 close to the needle 4 is fixedly connected to multiple pressure springs 502, the pressure spring 502 is located inside the slide 504, and the slide 504 is slidably connected to the protective cover 505. The protective cover 505 is fixedly connected to the pressure spring 502. The assembly and extrusion dosage of the insulin pen are completed by disassembling the pen barrel 1 and the pen core holder 2. The pen barrel 1 is equipped with a high-precision spiral propulsion dosage adjustment system. Combined with a micro-electromechanical sensor, real-time monitoring and feedback are provided during the rotation and dosage adjustment process, ensuring that the error of each dosage output is controlled within a very small range and can be accurate to 0.01 units, meeting the refined medication needs of different patients;
[0021] The protective cover 505 is connected by sliding in the slide groove 504, and then the pressure spring 502 can be squeezed. When in use, the needle 4 is squeezed to contact the skin, and the bottom plate 503 is connected and fixed.
[0022] Combine Figure 1 The outer wall of the pen barrel 1 is fixedly connected to the feedback controller 6, and the outer side of the protective sleeve 505 is detachably connected to the pen cap 3. The pen cap 3 is located at one end of the injection needle 7. The bottom end of the pen barrel 1 is fixedly connected to the rope buckle 8. The feedback controller 6 has a built-in smart chip and a touch screen control interface, and has voice guidance and gesture recognition functions. The patient can complete the dosage setting, injection and other processes through simple voice commands or intuitive gestures; the device can automatically identify the type of insulin installed, give personalized injection suggestions according to the preset program, and wirelessly connect to the patient's mobile phone APP to upload injection data in real time, which is convenient for doctors to remotely monitor and adjust the treatment plan, greatly simplifying the operation and improving patient compliance. The pen cap 3 protects the pen core holder 2 and needle 4 after use.
[0023] Combine Figure 3 The front end of the needle 4 is fixedly connected to the injection needle 7 to reduce skin tissue damage during puncture and reduce pain. The inside of the pen cap 3 is fixedly connected to a silicone sleeve 9 that matches the injection needle 7. After use, the pen cap 3 contacts the protective sleeve 505, and then the silicone sleeve 9 protects the injection needle 7.
[0024] Working principle: when in use, take out the pen cap 3, then put the insulin into the pen core holder 2, install and fix the pen barrel 1, adjust the dosage control through the pen barrel 1, then aim the auxiliary mechanism 5 at the skin and press it. With the pressure, the protective cover 505 squeezes the pressure spring 502, so that the injection needle 7 is inserted subcutaneously for injection. After the injection is completed, the pressure spring 502 resets the protective cover 505 to form a cover to prevent the user from being afraid of the needle. Then the pen cap 3 and the pen core holder 2 are installed to protect them, and the pen core holder 2 and the needle 4 can be disassembled and reused repeatedly.
[0025] While embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions, and variations may be made to these embodiments without departing from the principles and spirit of the invention, and that the scope of the invention is defined by the appended claims and their equivalents.
Claims
1. An injection assist device for endocrinology clinics, characterized by: include; Pen holder (1), pen core holder (2) and pen cover (3); The pen holder (1) and the refill frame (2) are detachably connected. A needle (4) is provided at one end of the refill frame (2). An auxiliary mechanism (5) is provided on the outer wall of the refill frame (2). The auxiliary mechanism (5) comprises a sliding sleeve (501), a pressure spring (502) and a bottom plate (503). One end of the needle (4) close to the refill frame (2) is fixedly connected to the bottom plate (503). The bottom plate (503) is detachably connected to the refill frame (2). The outer wall of the needle (4) is fixedly connected to the sliding sleeve (501). A sliding groove (504) is provided on the outer wall of the sliding sleeve (501). A side of the bottom plate (503) close to the needle (4) is fixedly connected to a plurality of pressure springs (502). The pressure springs (502) are located inside the sliding groove (504). A protective cover (505) is slidably connected inside the sliding groove (504). The protective cover (505) is fixedly connected to the pressure spring (502).
2. The endocrine clinical injection assist device according to claim 1, characterized in that: The outer side wall of the pen holder (1) is fixedly connected with a feedback controller (6).
3. The endocrine clinical injection assist device according to claim 1, characterized in that The front end of the needle (4) is fixedly connected to an injection needle (7).
4. The endocrine clinical injection assist device according to claim 3, characterized in that: The outer side of the protective sleeve (505) is detachably connected to a pen cap (3), and the pen cap (3) is located at one end of the injection needle (7).
5. The endocrine clinical injection assist device according to claim 1, characterized in that: The bottom end of the pen holder (1) is fixedly connected with a rope buckle (8).
6. The endocrine clinical injection assist device according to claim 3, characterized in that: A silicone sleeve (9) adapted to the injection needle (7) is fixedly connected to the interior of the pen cap (3).